Sotrovimab cuts risk for COVID-19 progression in high-risk patients
Attorneys general warn about pot products that look like Halloween treats
29 October 2021Cognitive dysfunction fairly common after COVID-19 infection
29 October 2021Sotrovimab cuts risk for COVID-19 progression in high-risk patients
(HealthDay)—Sotrovimab reduces the risk for disease progression in high-risk patients with mild-to-moderate COVID-19, according to a study published online Oct. 27 in the New England Journal of Medicine.
